BackInter Parfums Overview

Inter Parfums Other Current Liabilities

Latest other current liabilities for IPAR: $150M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$146.17M
15.32% YoYΔ $19.41M vs prior year quarter

Peer trimmed avg / median

Loading

Inter Parfums Other Current Liabilities History

Loading

Inter Parfums vs. peers: Other Current Liabilities Comparison

Loading

Inter Parfums Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Inter Parfums (IPAR) FAQ

Inter Parfums posts a other current liabilities of $150M as of June 2026. That compares with $130M in the prior-year period — up 15.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Inter Parfums's other current liabilities was $130M. The latest reading is $150M — a 15.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Inter Parfums's financial statement story. At $150M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IPAR's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Inter Parfums's other metric pages and overview cover the third.

Judging Inter Parfums against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $150M here, then scan peer and history charts to see if the gap is persistent.